# Labeling law: why the back of the pack is a legal minefield
In 2018, Kind LLC's fruit and nut bars carried the word "healthy" on the front label. The US Food and Drug Administration (FDA) disagreed, because the bars' saturated fat content exceeded the threshold the agency required for that claim. Kind had to reformulate its labeling strategy, and the case became a textbook example of how one adjective can trigger a federal enforcement action. That word alone cost the company years of regulatory back-and-forth.
This is the back of the pack: a few square inches of text that carries more legal exposure than most of a company's marketing budget.
Marketing teams treat packaging as a canvas. Legal and regulatory affairs teams treat it as a filing. Both are right, which is exactly the problem.
Every claim on a label (nutrition content, health benefits, origin, "natural," "sustainable") is a factual assertion that a regulator can test against a legal standard. Get the wording, the substantiation, or the formatting wrong, and a label becomes evidence in a case, not just a sales tool.
Two regulatory systems dominate this space for any company selling into the US or EU:
In the US, the FDA's Nutrition Facts Label format is prescribed down to font size and line spacing (21 CFR 101.9). The 2016 update (fully phased in by 2020, still the current standard in 2026) added "Added Sugars" as a mandatory line, forcing reformulation disclosures across the entire packaged food aisle.
In the EU, FIC requires a "Big 7" nutrition declaration: energy, fat, saturates, carbohydrates, sugars, protein, and salt, per 100g/100ml. Front-of-pack schemes like France's Nutri-Score (a letter-grade system, A to E) are voluntary at the EU level but increasingly a de facto requirement in specific markets because retailers demand it.
Both systems require descending order by weight. Both require allergen disclosure. The EU mandates 14 specific allergens be emphasized (bold, underlined, or a different font) directly in the ingredient list itself, not in a separate box. The US equivalent, under the FASTER Act (2021), added sesame as the ninth major allergen requiring disclosure, effective January 2023.
Miss an allergen and you're not looking at a fine. You're looking at a recall. Undeclared allergens are consistently the single largest cause of US food recalls tracked by the FDA's recall database.
This is where most litigation lives. The FDA defines strict criteria for words like "healthy," "low fat," "light," and "natural" (the last of which, notably, still has no formal FDA definition as of 2026, creating years of consumer-lawsuit ambiguity). The FTC separately requires that any health claim be backed by "competent and reliable scientific evidence" before it reaches the package.
In the EU, the Nutrition and Health Claims Regulation (EC 1924/2006) is stricter still: a claim like "supports immune function" can only be used if the specific wording has been pre-approved and added to the EU Register of authorized health claims. Unauthorized claims are automatically illegal, no case-by-case argument required.
The US has a distinctive risk multiplier: class action lawsuits, often under state consumer protection statutes (California's Unfair Competition Law is the most litigated). Plaintiffs' firms specifically monitor labels for phrases like "natural," "no added sugar," or "made with real fruit" that don't match ingredient reality.
Notable pattern cases:
In the EU, enforcement tends to run through national authorities rather than private class actions, but the financial consequence is similar: product recalls, forced relabeling across an entire SKU range, and reputational damage that outlasts the fine itself.
Assume a mid-size snack brand sells 5 million units per year of a bar labeled "healthy" that gets challenged and must be reformulated or relabeled.
Even the low end of this stack (packaging plus relabeling alone, before any litigation) can exceed $200,000 for one mislabeled word. That is the cost of a comma-level compliance failure, before a single lawyer gets involved.
Knowledge check
1. What does the Kind LLC 'healthy' labeling case illustrate about front-of-pack marketing claims?
2. Why does the lesson describe the back of a product pack as a legal document rather than just a design asset?
3. A US company wants to run a social media ad claiming its snack 'boosts energy,' a claim not printed on the physical label. Which regulatory body's jurisdiction is most directly relevant to this claim?
4. Select ALL correct answers about the distinction between FDA and FTC roles in US food labeling regulation.
Select all the correct answers.
5. Select ALL correct answers about the EU Food Information to Consumers Regulation (FIC).
Select all the correct answers.
| Body | Jurisdiction | Core power |
|---|---|---|
| FDA | US | Sets label format and content rules, can seize products, issue warning letters |
| FTC | US | Polices truthfulness of claims across all marketing, not just labels |
| State AGs / class action bar | US | Civil litigation under consumer protection laws, often the real financial risk |
| National food safety authorities (per EU member state) | EU | Enforce FIC and health claims regulation, coordinate recalls |
| European Food Safety Authority (EFSA) | EU | Scientifically evaluates and pre-approves health claims before authorization |
The practical lesson for anyone in FMCG: legal, regulatory affairs, and marketing must sign off on labels jointly, before print, not after a competitor's lawsuit reveals the gap. Reformulation to avoid a compliance threshold (like Kind lowering saturated fat to legitimately earn "healthy") is often cheaper than defending the claim.
🎬 [VIDEO: "How Food Labels Are Regulated (and Often Misleading)" - https://www.youtube.com/results?search_query=how+food+labels+are+regulated+FDA+FTC - search for current explainer content from consumer-focused or regulatory-affairs channels covering FDA/FTC label enforcement]